News
= LISA News
23.01.2019
MARINOMED RESUMES OFFER PERIOD OF INITIAL PUBLIC OFFERING ON THE VIENNA STOCK EXCHANGE
16.01.2019
Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019
10.01.2019
AOP Orphan Pharmaceuticals AG and Chord Therapeutics Announce a Partnership to Develop CRD1 (Cladribine) for Treatment of Orphan Autoimmune Diseases
07.01.2019
HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead
07.01.2019
Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate
18.12.2018
Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate
18.12.2018
HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus